NIR-responsive Cu2 − xSe@Fc nanoparticles for photothermal- ferroptosis combination therapy in esophageal cancer
Open Access
- 17 May 2025
- journal article
- research article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 23 (1) , 1-21
Abstract
Esophageal cancer (EC) represents a highly recurrent and aggressive malignancy within the digestive system. However, conventional therapeutic strategies exhibit notable limitations in their clinical applications. Photothermal therapy (PTT), combined with ferroptosis, has attracted considerable attentions, emerging as a promising novel strategy for EC treatment. Therefore, there is a critical need to develop a drug delivery system capable of effectively integrating these two therapeutic approaches. In this work, we report a novel drug delivery system based on ferrocene (Fc), which is mixed with lauric acid (a phase-change material with a melting point around 44 oC) and then coated on the surface of Cu2 − xSe nanoparticles. The photothermal properties of Cu2 − xSe triggers the melting of lauric acid under near-infrared (NIR) laser irradiation, facilitating controlled release of Fc. Following internalization by tumor cells via endocytosis, the synergistic effect of PTT and ferroptosis, triggered by Cu2 − xSe@Fc, induced immunogenic cell death, which promoted dendritic cell maturation and cytotoxic T lymphocytes recruitment while decreasing the proportion of regulatory T cells, thereby strengthening the antitumor immune surveillance and improving the therapeutic efficacy of Anti-PD-1 blockade. These findings propose that the NIR-responsive Cu2 − xSe@Fc formulation represents a promising and effective strategy with prospecting application for cancer treatment.Keywords
Funding Information
- National Natural Science Foundation of China (82302966, 52102346)
- Key Projects of Medical Science and Technology of Henan Province (SBGJ202102199)
- Joint Fund of Henan Science and Technology Research (232103810048)
- Key Project of Medical and Health Development Project (2302016A)
This publication has 50 references indexed in Scilit:
- Nanocodelivery of an NIR photothermal agent and an acid-responsive TLR7 agonist prodrug to enhance cancer photothermal immunotherapy and the abscopal effectBiomaterials, 2023
- Protease‐Activatable Nanozyme with Photoacoustic and Tumor‐Enhanced Magnetic Resonance Imaging for Photothermal Ferroptosis Cancer TherapyAdvanced Functional Materials, 2022
- Tailoring core@shell structure of Cu2−xSe@PDAs for synergistic solar-driven water evaporationJournal of Materials Science, 2022
- Dual-responsive nanohybrid based on degradable silica-coated gold nanorods for triple-combination therapy for breast cancerActa Biomaterialia, 2021
- Ferroptosis, a novel pharmacological mechanism of anti-cancer drugsCancer Letters, 2020
- Targeting Ferroptosis to Iron Out CancerCancer Cell, 2019
- Combination cancer treatment through photothermally controlled release of selenous acid from gold nanocagesBiomaterials, 2018
- Emerging Strategies of Nanomaterial‐Mediated Tumor RadiosensitizationAdvanced Materials, 2018
- A Eutectic Mixture of Natural Fatty Acids Can Serve as the Gating Material for Near‐Infrared‐Triggered Drug ReleaseAdvanced Materials, 2017
- Understanding the Photothermal Conversion Efficiency of Gold NanocrystalsSmall, 2010